Can cefixime and azithromycin be co‑administered?

Can Cefixime and Azithromycin Be Given Together?

Yes, cefixime and azithromycin can be co-administered safely and are explicitly recommended together as an alternative regimen for gonorrhea treatment when ceftriaxone is unavailable. 1

Clinical Context and Rationale

The combination of cefixime with azithromycin represents a CDC-endorsed alternative treatment strategy, specifically designed to address two critical concerns:

• Dual antimicrobial coverage with different mechanisms of action to improve treatment efficacy
• Resistance mitigation to delay emergence and spread of cephalosporin resistance 1

Specific Recommendations for Gonorrhea

When ceftriaxone is not available, CDC guidelines explicitly recommend:

• Cefixime 400 mg orally as a single dose
• PLUS Azithromycin 1 g orally as a single dose (or doxycycline 100 mg twice daily for 7 days)
• PLUS Test-of-cure in 1 week 1

This combination is preferred over cefixime monotherapy because azithromycin provides additional coverage and helps prevent treatment failure, particularly important given declining cefixime susceptibility patterns observed in surveillance data 1.

Important Caveats

Cefixime is no longer a first-line regimen for gonorrhea treatment in the United States. The preferred first-line treatment remains ceftriaxone 250 mg IM plus azithromycin 1 g orally 1. Cefixime should only be used when ceftriaxone is truly unavailable because:

• Cefixime provides lower and less sustained bactericidal levels than ceftriaxone 1
• Limited efficacy for pharyngeal gonorrhea 1
• Rising minimum inhibitory concentrations (MICs) suggest declining effectiveness 1

Safety and Drug Interactions

No significant drug-drug interactions exist between cefixime and azithromycin based on FDA labeling 2, 3. The main drug interactions to monitor are:

For cefixime:

• Carbamazepine (elevated levels possible) 2
• Warfarin (increased prothrombin time) 2

For azithromycin:

• Generally well-tolerated with minimal clinically significant interactions 3

Evidence from In Vitro Studies

Multiple in vitro synergy studies support this combination:

• No antagonism detected in any tested gonococcal isolates 4, 5, 6
• Synergy or additive effects demonstrated in 76-100% of isolates depending on the study 4, 5
• Significant MIC reductions when cefixime combined with azithromycin (median cefixime MIC decreased from 0.25 to 0.008 μg/mL) 5

Beyond Gonorrhea: Other Clinical Applications

This combination has been studied for other infections:

• Typhoid fever: Combination therapy being evaluated in clinical trials for multidrug-resistant typhoid 7
• Respiratory infections: Demonstrated synergy against respiratory pathogens including K. pneumoniae (91% synergy rate) 8

Practical Implementation

When using cefixime plus azithromycin:

1. Administer both medications simultaneously as single doses
2. Schedule test-of-cure at 1 week at the infected anatomic site 1
3. Use culture or NAAT for test-of-cure; if NAAT positive, confirm with culture 1
4. Counsel patients to abstain from sexual intercourse until treatment completion and partner notification 1
5. If treatment fails, switch to ceftriaxone 250 mg IM plus azithromycin 2 g orally and consult infectious disease specialist 1

The combination is safe, well-tolerated, and explicitly recommended in CDC guidelines as an alternative when ceftriaxone is unavailable, though it should not replace ceftriaxone as first-line therapy.